'Insmed's (INSM) Quad Shot At Significant Upside'; PT Raised to $269 at TD Cowen
Tweet Send to a Friend
TD Cowen analyst Ritu Baral raised the price target on Insmed (NASDAQ: INSM) to $269.00 (from $231.00) while maintaining a ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
